• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gujarat Themis Biosyn Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Themis
  • BSE Code : 216.0
  • ISIN : INE942C01045
281.91 -14 (-4.86%)
  • As on 01 Apr 2025 (EOD)

  • Today’s Low

    277.00

  • Today’s High

    298.00

  • Open

    291.85

  • Perv Close

    296.30

  • 52W Low

    208.00

  • 52W High

    300.62

Key Indicators

  • P/E(TTM)

    58.28

  • Mar.Cap (₹Cr.)

    3,071.84

  • Div & Yield %

    0.24

  • Book Value(₹)

    20.51

  • Debt-Equity Ratio

    -4.86

  • AGM Date

    28-Mar-2025

  • EPS

    4.83

  • P/E Ratio

    58.28

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    3,071.84

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.90

  • BV (₹)

    20.50

  • Sales( ₹ in Cr.)

    169.82

  • NP (in Cr.)

    59.16

  • NP Var(%)

    2.0

  • Div%

    100.0

  • CPS (₹)

    5.80

  • EPS (₹)

    5.40

  • Traded Value (₹ in Lakhs)

    3,067.37

  • 52 Week High

    300.62

  • 52 Week Low

    208.00

  • Price BSE

    282.0

  • Price NSE

    282.00

  • Market Capital( in Cr.)

    3,067.37

  • P/C Ratio

    49.00

  • P/E Ratio

    51.90

  • Price Vs.BV

    5.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 169.82 148.39 114.85 90.56 85.12 41.05
Excise Duty 169.81 148.13 114.19 90.43 67.69 1.08
Net Sales 169.82 148.39 114.85 90.56 85.12 41.05
Other Income 4.37 6.59 4.05 3.27 1.70 2.21
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 174.19 154.97 118.90 93.83 86.83 43.26
EXPENDITURE :
Raw Materials 169.81 148.13 114.19 90.43 67.69 1.08
Power & Fuel Cost 169.81 148.13 114.19 90.43 67.69 1.08
Employee Cost 10.21 7.75 7.08 7.11 6.43 5.17
Other Manufacturing Expenses 0.61 0.64 1.15 0.53 0.49 0.35
Selling & Administrative Expenses 8.51 6.66 2.31 1.86 1.64 1.39
Miscellaneous Expenses 0.61 0.64 1.15 0.53 0.49 0.35
Less : Pre-operative Expenses Capitalised :
Total Expenditure 94.85 77.51 59.87 52.95 55.57 35.07
Operating Profit 35.07 33.21 29.64 25.36 33.38 25.48
Interest 0.23 0.18 0.83 0.98 0.92 0.16
Gross Profit 79.33 77.46 59.03 40.88 31.26 8.20
Depreciation 3.54 2.58 2.23 1.73 1.36 1.22
Profit Before Tax 79.33 77.46 59.03 40.88 31.26 8.20
Tax 19.51 19.24 15.01 10.35 7.64 0.87
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.38 0.26 0.07 0.13 -0.05 0.92
Reported Net Profit 59.16 57.97 43.62 30.18 23.67 6.41
Extraordinary Items 79.33 77.46 59.03 40.88 31.26 8.20
Adjusted Net Profit 59.16 57.97 43.62 30.18 23.67 6.41
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 7.26 7.85 15.98 0.00 2.40 0.00
P & L Balance carried down 59.16 57.97 43.62 30.18 23.67 6.41
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 100.00 108.00 220.00 0.00 33.00 0.00
Dividend Per Share(Rs) 5.00 5.40 11.00 0.00 1.65 0.00
Earnings Per Share-Unit Curr 40.72 39.90 30.03 20.77 16.30 4.41
Book Value 7.26 7.85 15.98 0.00 2.40 0.00
Book Value(Adj)-Unit Curr 7.26 7.85 15.98 0.00 2.40 0.00

Shareholding Pattern

  • Promoter Group

    70.86%

  • Public Share Holding

    29.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 76,512,037 70.22 76,512,037 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 706,046 0.65 706,041 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 77,218,083 70.86 77,218,078 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 750 0.00 750 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 250 0.00 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,607,361 1.48 1,607,361 8
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,269,169 1.16 1,255,169 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 10,250 0.01 0 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,887,780 2.65 2,863,280 16
2] Non Institution
Bodies Corporate 3,393,563 3.11 3,366,563 176
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 618,476 0.57 618,476 1
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,956,069 1.80 1,815,569 788
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,340,707 1.23 1,340,707 457
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,413,896 3.13 3,413,896 10
Individuals holding nominal share capital up to Rs. 1 lakh 18,134,691 16.64 17,127,306 28,976
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,000 0.00 750 2
Others 1,000 0.00 750 2
Sub Total 28,859,402 26.49 27,684,017 30,412
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 108,965,265 100.00 107,765,375 30,436

Company Background

Gujarat Themis Biosyn LtdPharmaceuticals - Indian - Bulk Drugs

  • Gujarat Themis Biosyn Ltd
  • BSE Code : 216.0
  • ISIN : INE942C01045

  • Incorporation Year

    1981

  • Registered Office

    69/C GIDC Industrial Estate
    Valsad Dist, VAPI,
    Gujarat-396195

  • Telephone

    91-260-2430027

  • FAX

    91-260-2400639

  • Chairman

    Dinesh S Patel

  • Managing Director

  • Company Secretary

    RAHUL DWARAKA SONI

  • Auditor

    GMJ & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Gujarat Themis Biosyn Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Novartis India 785.05 396.75 335.07 22.47 15.57
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92